Drug Type Small molecule drug |
Synonyms Wy 26002 |
Target |
Action antagonists |
Mechanism 5-HT receptor antagonists(Serotonin (5-HT) receptor antagonists) |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
License Organization- |
Drug Highest PhasePendingPreclinical |
First Approval Date- |
Regulation- |
Molecular FormulaC24H25N3O2 |
InChIKeyAQFFJGJVFJCQQL-UHFFFAOYSA-N |
CAS Registry80349-58-2 |
| KEGG | Wiki | ATC | Drug Bank |
|---|---|---|---|
| - | Panuramine | - | - |
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Depressive Disorder | Preclinical | United Kingdom | 25 May 1986 |





